Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use

Clinical and Experimental Medicine

Volumn 16, Issue 1, 2016, Pages 65-71

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Kawamura, Tomohiko ^a   Ishizuka, Takamitsu ^a   Okubo, Masaaki ^a   Nagasaka, Mitsuo ^a   Nakagawa, Yoshihito ^a   Arisawa, Tomiyasu ^b   Ohmiya, Naoki ^a   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; Gastric mucosa; H. pylori; NSAIDs; Telomere length; Ulcer diseases

Indexed keywords

CADHERIN; GENOMIC DNA; NONSTEROID ANTIINFLAMMATORY AGENT; PEPSINOGEN; CDH1 PROTEIN, HUMAN;

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH ULCER; TELOMERE SHORTENING; BLOOD; DRUG EFFECTS; GENETICS; HELICOBACTER INFECTIONS; MICROBIOLOGY; PROMOTER REGION; STOMACH MUCOSA; TELOMERE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CADHERINS; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; PROMOTER REGIONS, GENETIC; TELOMERE; TELOMERE SHORTENING;

EID: 84957970285     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-014-0335-0     Document Type: Article

References (45)

1. de Lange T. The protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–10.
2. Jennings BJ, Ozanne SE, Hales CN. Nutrition, oxidative damage, telomere shortening, and cellular senescence: individual or connected agents of aging? Mol Genet Metab. 2000;71:32–42.
3. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339–44.
4. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662–4.
5. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95:1211–8.
6. Schönland SO, Lopez C, Widmann T, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003;100:13471–6.
7. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–60.
8. Vulliamy T, Marrone A, Dokal I, et al. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168–70.
9. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6:611–22.
10. Chang S. Modeling aging and cancer in the telomerase knockout mouse. Mutat Res. 2005;576:39–53.
11. Hande MP, Samper E, Lansdorp P, et al. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol. 1999;144:589–601.
12. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.
13. Bailey SM, Murnane JP. Telomeres, chromosome instability and cancer. Nucleic Acids Res. 2006;34:2408–17.
14. Cheung AL, Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci. 2008;13:2075–90.
15. Murnane JP. Telomeres and chromosome instability. DNA Repair (Amst). 2006;5:1082–92.
16. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am. 1993;22:89–104.
17. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37.
18. Aida J, Izumiyama-Shimomura N, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38:1192–200.
19. Kuniyasu H, Kitadai Y, Mieno H, et al. Helicobacter pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology. 2003;65:275–82.
20. Maruyama Y, Hanai H, Fujita M, et al. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol. 1997;27:216–20.
21. Maruyama Y, Hanai H, Kaneko E. Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach. Nippon Rinsho. 1998;56:1186–9.
22. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984;77:19–24.
23. Wang JY, Yamasaki S, Takeuchi K, et al. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology. 1989;96:393–402.
24. Konturek PK, Brzozowski T, Konturek SJ, et al. Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology. 1990;99:1607–15.
25. Ukawa H, Yamakuni H, Kato S, et al. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci. 1998;43:2003–11.
26. Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94–8.
27. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.
28. Tahara T, Arisawa T, Shibata T, et al. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Int J Mol Med. 2007;20:373–8.
29. Shiroeda H, Tahara T, Shibata T, et al. Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases. Int J Mol Med. 2010;26:707–11.
30. Tahara T, Arisawa T, Shibata T, et al. Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects. Dig Dis Sci. 2009;54:1247–52.
31. Tahara T, Shibata T, Nakamura M, et al. Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci. 2010;55:54–9.
32. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.
33. Kekki M, Samloff IM, Varis K, et al. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol suppl. 1991;186:109–16.
34. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.
35. Yamamoto E, Toyota M, Suzuki H, et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol Biomarkers Prev. 2008;17:2555–64.
36. McGrath M, Wong JY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:815–9.
37. Risques RA, Lai LA, Himmetoglu C, et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res. 2011;71:1669–79.
38. Cheng Y, Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol. 2005;11:309–14.
39. Shen H, Sun WH, Xue QP, et al. Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro. J Gastroenterol Hepatol. 2006;21:754–8.
40. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.
41. Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102:1361–71.
42. Aslan R, Bektas A, Bedir A, et al. Helicobacter pylori eradication increases telomere length in gastric mucosa. Hepatogastroenterology. 2013;60:601–4.
43. Zhang ZX, Wang Y, Tao ZZ, et al. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Cancer Biother Radiopharm. 2014;29:289–94.
44. Tomisato W, Tsutsumi S, Hoshino T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–85.
45. Bindu S, Mazumder S, Dey S, et al. Non-steroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-κB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against non-steroidal anti-inflammatory drug. Free Radic Biol Med. 2003 [Epub ahead of print].